eGenesis Company
Xenotransplant
Investors
Industry:
Risk Mitigation
Estimated Revenue:
$10M to $50M
Investors Number:
27
Headquarters:
USA
Employee Number:
11-50
Investor Type:
Late Stage Venture
Total Funding:
$265.00
Founded Date:
2014
Last Funding Type:
Series C
Last Funding Date:
2021